Ingerslev H J, Hjort T
Fertil Steril. 1979 May;31(5):496-502. doi: 10.1016/s0015-0282(16)43992-0.
Sera from five groups of women were investigated by the tray agglutination technique for the presence of spermagglutinins: (1) 326 women from infertile couples, (2) 51 women in early pregnancy, (3) 65 women in advanced pregnancy, (4) 41 oral contraceptive users, and (5) 109 presumably fertile, nonpregnant women. By absorbing spermagglutinating sera with a cell-free eluate from spermatozoa, agglutination disappeared when due to a high-molecular weight compound with beta-mobility in preparative zone electrophoresis (denoted beta-spermagglutinin), whereas activity due to sperm antibodies was unchanged. Spermagglutinating sera occurred with comparable frequency among women from infertile couples, women in advanced pregnancy, and oral contraceptive users. The absorption study revealed agglutinating antibodies in a significantly higher frequency and in higher titers among women of infertile couples than among fertile women, in whom beta-spermagglutinins were found almost exclusively. These results demonstrate the importance of discriminating between sperm antibodies and beta-spermagglutinins in studies of sperm antibodies as a cause of infertility in women.
采用玻片凝集技术对五组女性血清进行检测,以确定是否存在精子凝集素:(1)326名来自不育夫妇的女性;(2)51名早孕女性;(3)65名孕晚期女性;(4)41名口服避孕药使用者;(5)109名推测具有生育能力的未孕女性。用精子的无细胞洗脱液吸收精子凝集血清时,若凝集是由制备区电泳中具有β迁移率的高分子量化合物(称为β-精子凝集素)引起的,则凝集消失,而由精子抗体引起的活性则保持不变。来自不育夫妇的女性、孕晚期女性和口服避孕药使用者中出现精子凝集血清的频率相当。吸收研究显示,不育夫妇女性中凝集抗体的频率和效价明显高于可育女性,而可育女性中几乎只发现了β-精子凝集素。这些结果表明,在研究精子抗体作为女性不育原因时,区分精子抗体和β-精子凝集素非常重要。